PYC

Physiomics PLC

Health Care First-pass screen £2.27m

340/1000 Overall fit

AI beneficiary 35% 32

Operating leverage 25% 44

Valuation 25% 30

Downside protection 15% 32

First-pass take

Physiomics provides mathematical modelling and biostatistics consulting to biotech/pharma companies, with 46% YoY revenue growth but still loss-making (£415k annual loss, ~8-month cash runway). Services use AI/ML tools but aren't AI-driven; demand exposed to pharma R&D cycles, not AI spending.

Flags

loss-makingmicro-captight-cash-runwayno-valuation-datapre-profitabilitycyclical